| Vol. 14.08 – 4 March, 2022 |
| |
|
|
| Mechanistically, interferon γ stimulated ACSL4 and altered tumor cell lipid pattern, thereby increasing incorporations of arachidonic acid into C16 and C18 acyl chain-containing phospholipids. [Cancer Cell] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Scientists found that accompanying with dedifferentiation, long-term cultured proliferating human hepatocytes upregulated a panel of chemokines and cytokines related to innate immunity, which were referred as dedifferentiation-associated inflammatory factors. [Hepatology] |
|
|
|
| Researchers found that accompanying with dedifferentiation, long-term cultured ProliHH upregulated a panel of chemokines and cytokines related to innate immunity, which were referred as dedifferentiation-associated inflammatory factors. [Hepatology] |
|
|
|
| In their investigation of how B cell antigen receptor signaling was restored in Cd45−/− cells, scientists found that the coreceptor CD22 switched from an inhibitory to a stimulatory function in these cells. [Science Signaling] |
|
|
|
| Investigators demonstrated that PKCθ/β-dependent CARD11 phosphorylation also suppressed CARD11 functions in T or B cells. [Science Signaling] |
|
|
|
| The authors performed flow cytometry and single-cell RNA sequencing to examine the immune cell landscape of excisional wounds from Angptl4+/+ and Angptl4−/− mice. [Cell Death & Disease] |
|
|
|
| Researchers developed a protocol to generate stable numbers of liver-located CD8 T cells, and used intravital microscopy to record movement patterns of CD8 T cells in livers of live mice. [Journal of Immunology] |
|
|
|
| Investigators demonstrated that dominant negative TGF-β receptor type II specifically targeting T cells decreased tumor load in tumor-bearing mice. [Biomedicine & Pharmacotherapy] |
|
|
|
| Scientists generated thymus-complemented chimeric mice, assessed the efficacy of anti-PD-L1 antibody in tumor-bearing chimeric mice, and then investigated T cell function. [Scientific Reports] |
|
|
|
|
| Investigators summarize recent progress in relevant studies regarding the physiological and pathophysiological functions of mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1), post-translational modifications of MALT1, and its role in B cell- and T cell-related diseases. [Biochemical Pharmacology] |
|
|
|
| Few studies have examined in detail the relationship between drug eruptions, a major symptom of drug allergy, and systemic autoimmune diseases, and their actual status remains unclear. [Allergology International] |
|
|
|
|
| University of Utah (U of U) Health researchers will lead a five-year, $22-million nationwide clinical trial for NMDA receptor encephalitis –– a type of autoimmune encephalitis that prompts the immune system to mistakenly attack the brain. [University of Utah] |
|
|
|
| The University of Rochester Medical Center was recently funded to join a prestigious network of academic and clinical researchers, the National Institutes of Health (NIH) Accelerating Medicines Partnership®: Autoimmune and Immune-Mediated Diseases program. [University of Rochester] |
|
|
|
|
| March 9 – 12, 2022 Munich, Germany |
|
|
|
|
|
| Monash University – Clayton, Australia |
|
|
|
| University of Virginia School of Medicine – Charlottesville, Virginia, United States |
|
|
|
| Amsterdam UMC – Amsterdam, Netherlands |
|
|
|
| National Institute for Health and Medical Research – Paris, France |
|
|
|
| Genetech – South San Francisco, California, United States of America |
|
|
|
|